Other and unspecified vasculitis limited to skin

L12_VASCULITISNAS

hypersensitivity vasculitis: Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L95.8, L95.9
Cause of death: ICD-10 L95.8, L95.9

2 out of 7 registries used, show all original rules.

672

diagram downward connector

Check minimum number of events None

672

diagram downward connector

Include endpoints None

672

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

647

diagram downward connector
L12_VASCULITISNAS

Control definitions

Control exclude L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 647 371 276
Unadjusted prevalence (%) 0.16 0.16 0.15
Mean age at first event (years) 58.97 58.15 60.06

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.04 [1.07, 8.59] 3.7e-2 121
15 years 0.01 1.22 [0.46, 3.28] 6.9e-1 39
5 years 0.01 4.75 [2.24, 10.09] 4.9e-5 45
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_VASCULITISNAS – Other and unspecified vasculitis limited to skin
GWS hits:

Survival analyses between endpoints

Plot

before Other and unspecified vasculitis limited to skin
after Other and unspecified vasculitis limited to skin

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other and unspecified vasculitis limited to skin

Endpoint not on priority list, no data to show.